These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21520381)

  • 1. Retrospective comparison of single versus two stents for PCI of distal unprotected LMCA disease: apples aren't oranges and inverse probability weighting won't make them so!
    Moussa ID
    Catheter Cardiovasc Interv; 2011 May; 77(6):783-4. PubMed ID: 21520381
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.
    Kim WJ; Kim YH; Park DW; Yun SC; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):775-82. PubMed ID: 21520380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry).
    Godino C; Parodi G; Furuichi S; Latib A; Barbagallo R; Goktekin O; Cera M; Mueller R; Tamburino C; Grube E; Di Mario C; Reimers B; Chieffo A; Antoniucci D; Colombo A; Sangiorgi GM
    EuroIntervention; 2010 Apr; 5(8):906-16. PubMed ID: 20542775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 7. It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):949-50. PubMed ID: 21108371
    [No Abstract]   [Full Text] [Related]  

  • 8. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 10. Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 May; 77(6):773-4. PubMed ID: 21520379
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes and drug-eluting stents: what you get and what you don't.
    Marso SP
    JACC Cardiovasc Interv; 2008 Apr; 1(2):148-9. PubMed ID: 19463292
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of target-lesion revascularisation between left main coronary artery bifurcations and left anterior descending coronary artery bifurcations using the one and two stent approach with sirolimus-eluting stents.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Okimoto T; Otsuka M; Tamekiyo H; Tamura T; Kadota K; Inoue K; Mitsudo K;
    EuroIntervention; 2011 Nov; 7(7):796-804. PubMed ID: 22082575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let it be, let it be.
    Butman SM
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):898. PubMed ID: 19455656
    [No Abstract]   [Full Text] [Related]  

  • 15. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 16. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
    Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of drug-eluting stents in women: a window of opportunity.
    Jacobs AK
    JACC Cardiovasc Interv; 2009 Jul; 2(7):611-3. PubMed ID: 19628182
    [No Abstract]   [Full Text] [Related]  

  • 19. My stent is better than your stent...Or is it?
    Bates ER; Menees DS
    JACC Cardiovasc Interv; 2011 May; 4(5):551-3. PubMed ID: 21596328
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravascular ultrasound optimization of drug-eluting stents: still not enough data.
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):584-5. PubMed ID: 20333656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.